| 000 | 01188 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512200539.0 | ||
| 264 | 0 | _c19850321 | |
| 008 | 198503s 0 0 eng d | ||
| 022 | _a0165-1781 | ||
| 024 | 7 |
_a10.1016/0165-1781(84)90055-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerényi, A | |
| 245 | 0 | 0 |
_aBiochemical markers in the study of clinical effects and extrapyramidal side effects of neuroleptics. _h[electronic resource] |
| 260 |
_bPsychiatry research _cOct 1984 |
||
| 300 |
_a119-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDopamine beta-Hydroxylase _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xblood |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBagdy, G | |
| 700 | 1 | _aArató, M | |
| 700 | 1 | _aFrecska, E | |
| 773 | 0 |
_tPsychiatry research _gvol. 13 _gno. 2 _gp. 119-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0165-1781(84)90055-6 _zAvailable from publisher's website |
| 999 |
_c6151785 _d6151785 |
||